Denise Faustman, MD, PHd
Dr. Denise Faustman

Get updates on our research
Keep in touch with the Faustman Lab. Sign up for e-mail updates on the clinical trials and more.
>Sign up

Clinical Trials Information
For questions about the clinical trial, please e-mail us directly.
>E-mail us

twitterFollow us

video Video
Watch Dr. Faustman's interview about the Phase I trial

Help Support Our
Phase II Clinical Trial!

We have raised $16 million for the Phase II BCG human clinical trial in type 1 diabetes.

Our total need: $25.2 million.

You can help accelerate this research with a donation that will directly support this goal.

The Faustman Lab at Massachusetts General Hospital

Denise L. Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. She has worked in the field of autoimmunity for nearly two decades. In 2001, the Faustman Lab reversed type 1 diabetes in mice with end-stage disease, a project that is now in human clinical trials. Dr. Faustman’s current research continues to focus on uncovering new treatments for type 1 diabetes, as well as searching for therapies for other autoimmune diseases, including Crohn's disease, lupus, scleroderma, rheumatoid arthritis, Sjögren's syndrome, and multiple sclerosis.

Dr. Faustman’s earlier research achievements include key discoveries regarding the role of MHC Class I antigen presentation in immunity and introducing the concept of modifying antigens on donor tissues to prevent their rejection.  After completing her internship, residency, and fellowships in Internal Medicine and Endocrinology at the MGH, Dr. Faustman became an independent investigator at the MGH and Harvard Medical School in 1987. She is a member of the American Association for the Advancement of Science (AAAS) and serves as a frequent member of the Institute of Medicine in Washington, DC.

Dr. Faustman's honors in recent years include:

EVENING ON BROADWAY!
Please join us as the guest of Broadway legend Stephen Schwartz for a special evening on Broadway to raise funds for the Phase II trial.

Proceeds from the June 11, 2013 performance of Pippin (www.pippinthemusical.com) at the Music Box Theater will be donated to our fundraising efforts. We have a block of the very best seats reserved for friends of the clinical trial. Tickets are $400/person and include a private post-show reception with the cast at the theater.

To learn more about the event and to purchase tickets, please email Lynne Murphy or click here